ARCH leads $130M infusion into Be Bio’s long pursuit of B cell therapies for rare disease, cancer April 14, 2022
Be Bio Closes $130 Million Financing to Pioneer Engineered B Cells, a New Class of Cellular Medicines April 14, 2022
Sitryx Therapeutics Strengthens Leadership Team With Appointment of Ravi M. Rao as Chief Medical Officer April 12, 2022
Neuro player Jazz Pharmaceuticals Dives into Immuno-Oncology, Inking Cytokine Pact with Werewolf April 8, 2022
Bicycle Therapeutics Announces Updated Preclinical Data on SARS-CoV-2 Antivirals at the 2022 Microbiology Society Annual Meeting April 8, 2022
